346 results on '"Shimohigashi Y"'
Search Results
2. Agonist-antagonist structure-activity relationships of thrombin receptor tethered ligand peptide
3. Structural essentials for novel inhibition of serine protease chymotrypsin
4. Characterization and evolutionary aspect of a Trimeresurus flavoviridis serum inhibitor, PLI-I, against its venom basic phospholipase A2 isozymes
5. Structural requirements of hyperalgesic nociceptin in receptor binding and activation
6. Molecular Evolution of Snake Toxins: Is the Functional Diversify of Snake Toxins Associated with a Mechanism of Accelerated Evolution?
7. Applicability of Diagnostic Position PET/CT Images Using a Rigid Image Registration Technique to Delineation of Gross Tumor Volumes for Nasopharyngeal Carcinoma Radiotherapy: An Observer Study
8. EP-1956 Image quality of in-treatment 4D-CBCT obtained at various doses in VMAT for SBRT: a phantom study
9. PO-0797 Impact of 99mTc-GSA SPECT image-guided inverse planning on DFH parameters for SBRT planning for HCC
10. EP-2093: Dose–function histogram evaluation using 99mTc-GSA SPECT/CT images for SBRT planning for HCC
11. Plan Quality and Delivery Time Comparisons Between Volumetric Modulated Arc Therapy and Intensity Modulated Radiation Therapy for Scalp Angiosarcoma: A Planning Study Using X-ray Voxel Monte Carlo Algorithm
12. SU‐G‐JeP4‐06: Evaluation of Interfractional and Intrafractional Tumor Motion in Stereotactic Liver Radiotherapy, Based On Four‐Dimensional Cone‐Beam Computed Tomography Using Fiducial Markers
13. SU‐F‐T‐549: Validation of a Method for in Vivo 3D Dose Reconstruction for SBRT Using a New Transmission Detector
14. SU-F-T-541: Impact of VMAT Dose Calculations with Respiratory Movements in Lung
15. Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system
16. SU‐E‐T‐336: Dosimetric Properties of a New Solid Water High Equivalency Phantom for High‐Energy Photon Beams
17. Structural requirements of hyperalgesic nociceptin in receptor binding and activation
18. A novel type of rat brain β opioid receptors differenciated by cyclopropylphenylalanine-containing enkephalin analog
19. Characterization and evolutionary aspect of a Trimeresurus flavoviridis serum inhibitor, PLI-I, against its venom basic phospholipase A2 isozymes
20. Agonist-antagonist structure-activity relationships of thrombin receptor tethered ligand peptide
21. Structural essentials for novel inhibition of serine protease chymotrypsin
22. Fine spatial assembly for construction of the phenol-binding pocket to capture bisphenol A in the human nuclear receptor estrogen-related receptor
23. SU-E-T-129: Angular Dependence and Its Correction of the MatriXXEvolution System for IMRT and VMAT Dose Verification
24. Endocrine Disrupter Bisphenol A Increases In Situ Estrogen Production in the Mouse Urogenital Sinus
25. ChemInform Abstract: Synthesis of Cyclopropane Amino Acids and Their Incorporation into Bioactive Peptides as Conformational Constraint
26. Distinction of the binding modes for human nuclear receptor ERR between bisphenol A and 4-hydroxytamoxifen
27. Placenta Expressing the Greatest Quantity of Bisphenol A Receptor ERR among the Human Reproductive Tissues: Predominant Expression of Type-1 ERR Isoform
28. Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol Z
29. Crystal structure of human estrogen-related receptor gamma ligand binding domain apo form
30. Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with 4-alpha-cumylphenol, a bisphenol A derivative
31. Direct Measure of Fluorescence Intensity for Efficient Receptor-binding Assay: Conjugates of Ethinylcarboxyestradiol and 5(and 6)-Carboxyfluorescein via , -Diaminoalkanes as a Tracer for Estrogen Receptor
32. Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol A
33. Structural Evidence for Endocrine Disruptor Bisphenol A Binding to Human Nuclear Receptor ERR
34. Double-labelled in situ Hybridization Reveals the Lack of Co-localization of mRNAs for the Circadian Neuropeptide PDF and FMRFamide in Brains of the Flies Musca domestica and Drosophila melanogaster
35. Two-step models to predict binding affinity of chemicals to the human estrogen receptor α by three-dimensional quantitative structure–activity relationships (3D-QSARs) using receptor-ligand docking simulation
36. cDNA Cloning and Nuclear Localization of the Circadian Neuropeptide Designated as Pigment-Dispersing Factor PDF in the Cricket Gryllus bimaculates
37. Edge-to-Face CH/"" Interaction between Ligand Phe-Phenyl and Receptor Aromatic Group in the Thrombin Receptor Activation
38. Design and Synthesis of para-Fluorophenylalanine Amide Derivatives as Thrombin Receptor Antagonists
39. Exploration of Universal Cysteines in the Binding Sites of Three Opioid Receptor Subtypes by Disulfide-Bonding Affinity Labeling with Chemically Activated Thiol-Containing Dynorphin A Analogs
40. Interaction Mode of the Phe-Phenyl Group of Thrombin Receptor-Tethered Ligand SFLLRNP in Receptor Activation
41. Evidence for Functional Involvement of Asparagine 67 in Substrate Recognition by Snake Venom Phospholipases A2
42. Reversible Affinity Labeling of Opioid Receptors via Disulfide Bonding: Discriminative Labeling of and Subtypes by Chemically Activated Thiol-Containing Enkephalin Analogs
43. Chymotrypsin Inhibition Induced by Side Chain-Side Chain Intramolecular CH/ Interaction in D-Thr-L-Phe Benzylamide
44. Accelerated evolution of snake venom phospholipase A2 isozymes to acquire diverse functions
45. Lysine-49-Phospholipases A2 from Trimeresurus flavoviridis Venom Are Membrane-Acting Enzymes
46. Accelerated evolution in the protein-coding regions is universal in crotalinae snake venom gland phospholipase A2 isozyme genes.
47. Differential Roles of Two Consecutive Phenylalanine Residues in Thrombin Receptor-Tethered Ligand Peptides (SFFLRNP) in Thrombin Receptor Activation
48. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
49. Darwinian evolution of Trimeresurus flavoviridis venom gland phospholipase A2 isozymes
50. Receptor-Mediated Specific Biological Activity of a β-Amyloid Protein Fragment for NK-1 Substance P Receptors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.